Research publication on BMJ Open (2013) - "A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial"

Read the article on Omega-3, Omega-6 and antioxidant vitamins for older adults

New directives from American Heart Association - "Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease"

Our company “Palupa Medical Ltd.” is pleased to announce that in an effort to promote the Neuroaspis® PLP10 in world markets has entered into an agreement with “Gemworth Investments Ltd” by granting commercial rights and production of Neuroaspis® PLP10 for a number of countries including USA, Canada, Brazil, Australia, New Zealand, China, India, Russia, Japan, and many more .

Neuroaspis® PLP10 was presented at the 7th International Conference on Drug Discovery and Therapy, Dubai, February 2016. The session on Neuroaspis® PLP10 (see abstract) was presented by Prof. Dr I. Patrikios.

Our company” Palupa Medical Ltd.” is pleased to announce that in an effort to promote the Neuroaspis® PLP10 in world markets has entered into an agreement with “Aniva International sa” by granting commercial rights and production of Neuroaspis® PLP10 for a number of countries including Greece.

To 3ο Πανελλήνιο Συνέδριο της Ελληνικής Ακαδημίας Νευροανοσολογίας έγινε μεταξύ 19-22 Νοεμβρίου 2015 στο Ίδρυμα Ευγενίδου & στο ξενοδοχείο Metropolitan στην Αθήνα.